Sissetulev kiriAvalik
Farmakopöa tööplaani asjus
Ravimiamet · 17. mai 2024
- Viit
- REP-1/1807-1
- Registreeritud
- 17. mai 2024
- Dokumendi liik
- Sissetulev kiri
- Adressaat
- European Directorate for the Quality of Medicines & HealthCare
- Saabumis/saatmisviis
- e-post
- Funktsioon
- REP Euroopa Farmakopöaga seotud asjaajamine
- Sari
- REP-1 Euroopa Farmakopöa alane kirjavahetus
- Toimik
- REP-1/2024
- Vastutaja
- Signe Leito (RA, Labor)
Sisu (failidest)
Signe Leito
Saatja: [email protected]
Saatmisaeg: neljapäev, 25. aprill 2024 15:39
Adressaat: Signe Leito
Teema: For action: Proposed deletion of Diclazuril for veterinary use from the WP of Group 10B: EDQM-2024-01763-mail
Tähelepanu! Tegemist on väljastpoolt asutust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada.
Please make sure to include in any reply our mail reference: EDQM-2024-01763-mail
****************************************************************************
For the attention of NPAs
Copy: Presidium
Dear Colleagues,
Please find below the link to a survey being carried out concerning the proposed deletion of Diclazuril for veterinary use (1718) from the work programme of Group 10B.
In order to have access to the survey, please copy and paste the link into your Internet browser:
https://survey.edqm.eu/index.php?r=survey/index&sid=546484&newtest=Y&lang=en
Deadline for replies: 28 May 2024
Thank you.
With kind regards
On behalf of Dr Sylvina Iossiphova
Villy Nikolova
Administrative Support Assistant
European Pharmacopoeia Department
EDQM
Council of Europe
Tel.: +33 (0)3 90 21 64 63 / Fax: +33 (0)3 88 41 27 71
https://www.edqm.eu / https://www.edqm.eu/store
1
Stay connected with the EDQM
****************************************************************************
Please make sure to include in any reply our mail reference: EDQM-2024-01763-mail
2